|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.879
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.784
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.771
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.586
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.520
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.490
|
|
|
|
positive t cell selection
|
GO:0043368 |
23 |
0.458
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.431
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.411
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.408
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.393
|
|
|
|
v d j recombination
|
GO:0033151 |
14 |
0.381
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.304
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.288
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.286
|
|
|
|
positive regulation of regulatory t cell differentiation
|
GO:0045591 |
4 |
0.276
|
|
|
|
b cell homeostasis
|
GO:0001782 |
34 |
0.264
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.256
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.233
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.232
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.203
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.198
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.187
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.185
|
|
|
|
apoptotic process involved in mammary gland involution
|
GO:0060057 |
4 |
0.182
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.175
|
|
|
|
regulation of alpha beta t cell differentiation
|
GO:0046637 |
35 |
0.166
|
|
|
|
cellular response to gamma radiation
|
GO:0071480 |
4 |
0.164
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.163
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.161
|
|
|
|
post embryonic organ morphogenesis
|
GO:0048563 |
8 |
0.159
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.158
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.157
|
|
|
|
b cell lineage commitment
|
GO:0002326 |
4 |
0.156
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.152
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.146
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.139
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.137
|
|
|
|
t cell receptor v d j recombination
|
GO:0033153 |
5 |
0.133
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.130
|
|
|
|
thymus development
|
GO:0048538 |
41 |
0.129
|
|
|
|
regulation of b cell mediated immunity
|
GO:0002712 |
37 |
0.121
|
|
|
|
regulation of interleukin 10 secretion
|
GO:2001179 |
4 |
0.117
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.116
|
|
|
|
mitochondrial outer membrane permeabilization involved in programmed cell death
|
GO:1902686 |
11 |
0.116
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.115
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
42 |
0.115
|
|
|
|
regulation of mitochondrion organization
|
GO:0010821 |
27 |
0.114
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.112
|
|
|
|
somatic diversification of immune receptors
|
GO:0002200 |
53 |
0.109
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.109
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.108
|
|
|
|
cd4 positive or cd8 positive alpha beta t cell lineage commitment
|
GO:0043369 |
8 |
0.106
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.106
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.106
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.105
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.104
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.102
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.099
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.096
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.094
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.094
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.093
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.092
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.092
|
|
|
|
regulation of b cell differentiation
|
GO:0045577 |
23 |
0.091
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.091
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.091
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.089
|
|
|
|
regulation of mammary gland involution
|
GO:1903519 |
4 |
0.088
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.088
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
48 |
0.087
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.086
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.086
|
|
|
|
somatic recombination of immunoglobulin gene segments
|
GO:0016447 |
42 |
0.085
|
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
19 |
0.082
|
|
|
|
cellular process regulating host cell cycle in response to virus
|
GO:0060154 |
3 |
0.082
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.081
|
|
|
|
intrinsic apoptotic signaling pathway in response to oxidative stress
|
GO:0008631 |
19 |
0.080
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.079
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.077
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.075
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.073
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.073
|
|
|
|
positive regulation of skeletal muscle fiber development
|
GO:0048743 |
3 |
0.072
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.072
|
|
|
|
somatic diversification of immune receptors via germline recombination within a single locus
|
GO:0002562 |
51 |
0.071
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.071
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.070
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.070
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.068
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.067
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.065
|
|
|
|
positive regulation of protein homooligomerization
|
GO:0032464 |
3 |
0.065
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.064
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.064
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.062
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.061
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.061
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.060
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.059
|
|
|
|
interleukin 10 secretion
|
GO:0072608 |
4 |
0.059
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.058
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.058
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.056
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.055
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.055
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.055
|
|
|
|
apoptotic process involved in embryonic digit morphogenesis
|
GO:1902263 |
3 |
0.054
|
|
|
|
cochlear nucleus development
|
GO:0021747 |
4 |
0.053
|
|
|
|
somatic recombination of t cell receptor gene segments
|
GO:0002681 |
5 |
0.053
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.052
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.052
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.052
|
|
|
|
apoptotic process involved in morphogenesis
|
GO:0060561 |
25 |
0.052
|
|
|
|
positive regulation of apoptotic process involved in mammary gland involution
|
GO:0060058 |
4 |
0.051
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.051
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.049
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.049
|
|
|
|
cellular hyperosmotic salinity response
|
GO:0071475 |
0 |
0.049
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.049
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.048
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.048
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.047
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.047
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.047
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.047
|
|
|
|
immunoglobulin secretion
|
GO:0048305 |
17 |
0.046
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.046
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.046
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.045
|
|
|
|
neuron maturation
|
GO:0042551 |
29 |
0.042
|
|
|
|
fibroblast apoptotic process
|
GO:0044346 |
9 |
0.042
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.042
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.041
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.041
|
|
|
|
positive regulation of apoptotic process involved in morphogenesis
|
GO:1902339 |
4 |
0.041
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.041
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.040
|
|
|
|
endoplasmic reticulum calcium ion homeostasis
|
GO:0032469 |
11 |
0.040
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.039
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.039
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.038
|
|
|
|
negative regulation of peptidyl serine phosphorylation
|
GO:0033137 |
10 |
0.038
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.038
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.038
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.038
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.038
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.038
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.037
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.037
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.036
|
|
|
|
viral process
|
GO:0016032 |
41 |
0.036
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.036
|
|
|
|
interleukin 5 secretion
|
GO:0072603 |
2 |
0.036
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.036
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process by cytochrome c
|
GO:0008635 |
4 |
0.035
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.035
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.035
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.035
|
|
|
|
positive regulation of oxidative stress induced neuron intrinsic apoptotic signaling pathway
|
GO:1903378 |
3 |
0.034
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.034
|
|
|
|
post embryonic camera type eye development
|
GO:0031077 |
8 |
0.034
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.034
|
|
|
|
t cell lineage commitment
|
GO:0002360 |
13 |
0.033
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.032
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.032
|
|
|
|
b cell receptor signaling pathway
|
GO:0050853 |
20 |
0.032
|
|
|
|
t cell receptor signaling pathway
|
GO:0050852 |
46 |
0.032
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.032
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.032
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.032
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.032
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.031
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.031
|
|
|
|
cellular response to virus
|
GO:0098586 |
7 |
0.031
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.031
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.031
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.031
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.031
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.030
|
|
|
|
response to uv b
|
GO:0010224 |
5 |
0.030
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.030
|
|
|
|
positive regulation of killing of cells of other organism
|
GO:0051712 |
3 |
0.030
|
|
|
|
regulation of oxidative stress induced neuron intrinsic apoptotic signaling pathway
|
GO:1903376 |
3 |
0.030
|
|
|
|
positive regulation of intrinsic apoptotic signaling pathway
|
GO:2001244 |
25 |
0.030
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.030
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.030
|
|
|
|
regulation of killing of cells of other organism
|
GO:0051709 |
4 |
0.029
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.029
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.029
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.029
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.029
|
|
|
|
t cell homeostasis
|
GO:0043029 |
35 |
0.029
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.029
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.029
|
|
|
|
regulation of developmental pigmentation
|
GO:0048070 |
14 |
0.029
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.029
|
|
|
|
positive regulation of mammary gland involution
|
GO:1903521 |
4 |
0.028
|
|
|
|
peptidyl tyrosine dephosphorylation
|
GO:0035335 |
23 |
0.028
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.028
|
|
|
|
apoptotic process involved in patterning of blood vessels
|
GO:1902262 |
6 |
0.028
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.027
|
|
|
|
t cell apoptotic process
|
GO:0070231 |
39 |
0.027
|
|
|
|
positive regulation of b cell activation
|
GO:0050871 |
49 |
0.027
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.027
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.027
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.027
|
|
|
|
cell aging
|
GO:0007569 |
35 |
0.026
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic signaling pathway
|
GO:0097296 |
2 |
0.026
|
|
|
|
positive regulation of alpha beta t cell differentiation
|
GO:0046638 |
28 |
0.026
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.026
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.026
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.026
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.026
|
|
|
|
double strand break repair via nonhomologous end joining
|
GO:0006303 |
10 |
0.026
|
|
|
|
mitochondrial outer membrane permeabilization
|
GO:0097345 |
10 |
0.026
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.026
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.025
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.025
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.025
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
34 |
0.025
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.025
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.025
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.025
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.025
|
|
|
|
regulation of interleukin 13 secretion
|
GO:2000665 |
2 |
0.025
|
|
|
|
serotonin production involved in inflammatory response
|
GO:0002351 |
4 |
0.025
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.025
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.024
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.024
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.024
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.024
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.024
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.024
|
|
|
|
negative regulation of endoplasmic reticulum calcium ion concentration
|
GO:0032471 |
3 |
0.024
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.024
|
|
|
|
serotonin secretion involved in inflammatory response
|
GO:0002442 |
4 |
0.024
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.024
|
|
|
|
humoral immune response mediated by circulating immunoglobulin
|
GO:0002455 |
14 |
0.024
|
|
|
|
modulation by virus of host process
|
GO:0019054 |
2 |
0.023
|
|
|
|
regulation of isotype switching to igg isotypes
|
GO:0048302 |
10 |
0.023
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.023
|
|
|
|
thymocyte apoptotic process
|
GO:0070242 |
19 |
0.023
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.023
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.023
|
|
|
|
t cell homeostatic proliferation
|
GO:0001777 |
4 |
0.023
|
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
31 |
0.023
|
|
|
|
regulation of b cell apoptotic process
|
GO:0002902 |
13 |
0.023
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.023
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.023
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.023
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.023
|
|
|
|
programmed necrotic cell death
|
GO:0097300 |
28 |
0.022
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.022
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.022
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.022
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.022
|
|
|
|
protein homooligomerization
|
GO:0051260 |
43 |
0.022
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.022
|
|
|
|
negative regulation of adaptive immune response
|
GO:0002820 |
25 |
0.022
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.022
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.022
|
|
|
|
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway
|
GO:0001844 |
4 |
0.022
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.022
|
|
|
|
post embryonic eye morphogenesis
|
GO:0048050 |
4 |
0.022
|
|
|
|
maintenance of apical basal cell polarity
|
GO:0035090 |
3 |
0.022
|
|
|
|
mitochondrion morphogenesis
|
GO:0070584 |
13 |
0.022
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.022
|
|
|
|
telomere capping
|
GO:0016233 |
4 |
0.022
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.022
|
|
|
|
mitochondrial membrane organization
|
GO:0007006 |
26 |
0.022
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.021
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.021
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.021
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.021
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.021
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.021
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.021
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.021
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.021
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.021
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.021
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.020
|
|
|
|
rna phosphodiester bond hydrolysis endonucleolytic
|
GO:0090502 |
10 |
0.020
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.020
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.020
|
|
|
|
positive regulation of neuron death
|
GO:1901216 |
28 |
0.020
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.020
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.020
|
|
|
|
regulation of nitrogen utilization
|
GO:0006808 |
2 |
0.020
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.020
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.020
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.020
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.020
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.020
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.020
|
|
|
|
somatic diversification of t cell receptor genes
|
GO:0002568 |
5 |
0.020
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.020
|
|
|
|
positive regulation of myeloid leukocyte mediated immunity
|
GO:0002888 |
14 |
0.020
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.020
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.019
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.019
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.019
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.019
|
|
|
|
non recombinational repair
|
GO:0000726 |
10 |
0.019
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.019
|
|
|
|
response to alkaloid
|
GO:0043279 |
34 |
0.019
|
|
|
|
regulation of interleukin 5 secretion
|
GO:2000662 |
2 |
0.019
|
|
|
|
neuron intrinsic apoptotic signaling pathway in response to oxidative stress
|
GO:0036480 |
3 |
0.019
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.019
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.019
|
|
|
|
peptidyl threonine modification
|
GO:0018210 |
31 |
0.019
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.018
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.018
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.018
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.018
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.018
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.018
|
|
|
|
somatic diversification of immunoglobulins involved in immune response
|
GO:0002208 |
36 |
0.018
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.018
|
|
|
|
positive regulation of mitochondrial membrane permeability involved in apoptotic process
|
GO:1902110 |
11 |
0.018
|
|
|
|
regulation of mammary gland epithelial cell proliferation
|
GO:0033599 |
12 |
0.018
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.018
|
|
|
|
pigment metabolic process
|
GO:0042440 |
32 |
0.018
|
|
|
|
modification by symbiont of host morphology or physiology
|
GO:0044003 |
4 |
0.018
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.018
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.018
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.018
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.018
|
|
|
|
positive regulation of developmental pigmentation
|
GO:0048087 |
6 |
0.018
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.018
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.018
|
|
|
|
somatic diversification of immunoglobulins
|
GO:0016445 |
43 |
0.018
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.018
|
|
|
|
negative regulation of antigen receptor mediated signaling pathway
|
GO:0050858 |
16 |
0.017
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.017
|
|
|
|
fear response
|
GO:0042596 |
33 |
0.017
|
|
|
|
regulation of dna methylation
|
GO:0044030 |
12 |
0.017
|
|
|
|
somatic cell dna recombination
|
GO:0016444 |
51 |
0.017
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.017
|
|
|
|
regulation of pigment cell differentiation
|
GO:0050932 |
7 |
0.017
|
|
|
|
response to hydrogen peroxide
|
GO:0042542 |
32 |
0.017
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.017
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.017
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.017
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.017
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.017
|
|
|
|
developmental pigmentation
|
GO:0048066 |
40 |
0.017
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.017
|
|
|
|
membrane fusion
|
GO:0061025 |
38 |
0.017
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.017
|
|
|
|
maintenance of epithelial cell apical basal polarity
|
GO:0045199 |
2 |
0.017
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.017
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.017
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.016
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.016
|
|
|
|
regulation of cell maturation
|
GO:1903429 |
13 |
0.016
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.016
|
|
|
|
glycolipid metabolic process
|
GO:0006664 |
25 |
0.016
|
|
|
|
regulation of regulatory t cell differentiation
|
GO:0045589 |
7 |
0.016
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.016
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway
|
GO:2001269 |
3 |
0.016
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.016
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.016
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.016
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.016
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.016
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.016
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.016
|
|
|
|
labyrinthine layer blood vessel development
|
GO:0060716 |
21 |
0.016
|
|
|
|
modulation by symbiont of host cellular process
|
GO:0044068 |
2 |
0.016
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.016
|
|
|
|
mitochondrial transport
|
GO:0006839 |
36 |
0.016
|
|
|
|
b cell selection
|
GO:0002339 |
3 |
0.016
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.015
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.015
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.015
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.015
|
|
|
|
positive regulation of cellular response to oxidative stress
|
GO:1900409 |
6 |
0.015
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.015
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.015
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.015
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.015
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.015
|
|
|
|
negative regulation of peptidyl tyrosine phosphorylation
|
GO:0050732 |
17 |
0.015
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.015
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.015
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
46 |
0.015
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.015
|
|
|
|
positive regulation of melanocyte differentiation
|
GO:0045636 |
5 |
0.015
|
|
|
|
regulation of protein homooligomerization
|
GO:0032462 |
3 |
0.014
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.014
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.014
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.014
|
|
|
|
positive regulation of cytokine biosynthetic process
|
GO:0042108 |
40 |
0.014
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.014
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
36 |
0.014
|
|
|
|
negative regulation of fibroblast proliferation
|
GO:0048147 |
14 |
0.014
|
|
|
|
killing by symbiont of host cells
|
GO:0001907 |
2 |
0.014
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.014
|
|
|
|
fatty acid transport
|
GO:0015908 |
28 |
0.014
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.014
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0006919 |
27 |
0.014
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.014
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.014
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.014
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.014
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
49 |
0.014
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.014
|
|
|
|
positive regulation of pigment cell differentiation
|
GO:0050942 |
5 |
0.014
|
|
|
|
negative regulation of cytoplasmic transport
|
GO:1903650 |
29 |
0.014
|
|
|
|
negative regulation of notch signaling pathway
|
GO:0045746 |
14 |
0.014
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.014
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.014
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.014
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.014
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.013
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.013
|
|
|
|
dna modification
|
GO:0006304 |
50 |
0.013
|
|
|
|
apoptotic process involved in development
|
GO:1902742 |
28 |
0.013
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.013
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.013
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.013
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.013
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.013
|
|
|
|
positive regulation of protein oligomerization
|
GO:0032461 |
4 |
0.013
|
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
27 |
0.013
|
|
|
|
b cell homeostatic proliferation
|
GO:0002358 |
2 |
0.013
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.013
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.013
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.013
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.013
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.013
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.013
|
|
|
|
glycosphingolipid metabolic process
|
GO:0006687 |
18 |
0.013
|
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
18 |
0.013
|
|
|
|
regulation of toll like receptor 4 signaling pathway
|
GO:0034143 |
4 |
0.013
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.013
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.013
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.012
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.012
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.012
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.012
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.012
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.012
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.012
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.012
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.012
|
|
|
|
negative regulation of inflammatory response to antigenic stimulus
|
GO:0002862 |
10 |
0.012
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.012
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.012
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.012
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.012
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.012
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.012
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.012
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.011
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.011
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
39 |
0.011
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.011
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.011
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.011
|
|
|
|
liposaccharide metabolic process
|
GO:1903509 |
27 |
0.011
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.011
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.011
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.011
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.011
|
|
|
|
response to nitric oxide
|
GO:0071731 |
4 |
0.011
|
|
|
|
dna catabolic process
|
GO:0006308 |
19 |
0.011
|
|
|
|
regulation of epidermal growth factor receptor signaling pathway
|
GO:0042058 |
13 |
0.011
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.011
|
|
|
|
modulation by virus of host morphology or physiology
|
GO:0019048 |
3 |
0.011
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.011
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.011
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.011
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.011
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.011
|
|
|
|
peptidyl threonine phosphorylation
|
GO:0018107 |
31 |
0.011
|
|
|
|
positive thymic t cell selection
|
GO:0045059 |
13 |
0.011
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.011
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.011
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.011
|
|